Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shortened vs Standard Specific Immunotherapy for Allergic Asthma
NCT00540150Phase 3Completed
- Sponsor
- Universitätsklinikum Frankfurt
- Start
- May 2004
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 3 trial of Novo-Helisen Depot in allergic asthma, sponsored by Universitätsklinikum Frankfurt. Started May 2004; status: completed.
02
Drugs
Novo-Helisen Depot
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00540150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540150.